Revive Research Institute
July Newsletter
 
 
Study Spotlight - Explore Our Gastrointestinal Research Studies
 
At Revive Research Institute, we have extensive experience with an array of investigational products with variant modes of delivery. To deliver the right solutions to our patients, we need to ask the right questions. Explore some of the GI Research Studies we are currently conducting at DigestIive Health Associates in collaboration with Revive Research Institute.
 
Revolo Biotherapeutics Study on Eosinophilic Esophagitis
 
Revive Research Institute at DHA is leading the country for patients in this study. We are conducting a Phase 2a, single-blind, placebo-controlled research study on an injectable investigational medicine for people with Active EoE (Eosinophilic Esophagitis). This clinical trial evaluates the first disease-modifying agent designed for treating EoE.
 
Read More
 
 
 
 
 
 
Eli Lilly’s Study on Crohn’s Disease
 
We are conducting a Phase 3 study on an injectable biologic agent for adults ages 18 to 80 with moderate to severe Crohn’s disease. This study is near the end of recruitment — only 50 patients are left until the study reaches its recruitment goal.
 
Read More
 
 
Neurogastrx Study on Gastroparesis
 
COMING SOON. A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Investigational Product Administered Orally to Patients with Gastroparesis. This Clinical Trial will assess an oral D₂ antagonist for the treatment of idiopathic or diabetic gastroparesis.
 
 
 
 
 
Bringing You & Your
Patients Great Opportunity
 
Revive Research Institute partners with primary and specialty physicians all around Michigan, Texas, and Arizona. We take care of the day-to-day Clinical Trial Operations while you focus on what you do best — save lives.
 
 
About Revive Research
 
Revive Research Institute is an expanding network of clinical investigator sites. We work with CROs, Biotechnological, and Pharmaceutical companies to conduct safe and efficient Phase I – IV Clinical Trials on different types of therapies.
 
LEARN MORE
 
 
 
 
28270 Franklin Rd, Southfield, MI 48034, United States
Call: +1 (313) 662-2235
Email: DHAresearch@rev-research.com
 
 
Copyright © 2022 Revive Research Institute, Inc.